Document
type: Class

Continuant
type: Class

Entity
type: Class

234111
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Grant
type: Continuant
funding vehicle for: Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study

Generically Dependent Continuant
type: Class

individual
rights: termsOfUse
date: 2026-08-24T21:51:17
publisher: vivo
type: Document
label: RDF description of Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study - http://orbis.uaslp.mx/vivo/individual/scopus6028

Biomedical Chromatography
type: Periodical
type: Information Content Entity
type: Document
type: Generically Dependent Continuant
type: Thing
type: Continuant
publication venue for: Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study
type: Entity
type: Collection
type: Journal

Article
type: Class

Information Content Entity
type: Class

Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study
e iscopus: 2-s2.0-85071952423
origen: scopus
date time value: article date 6029
has publication venue: Biomedical Chromatography
abstract: An analytical method to identify volatile organic compounds (VOCs) in the exhaled breath from patients with a diagnosis of chronic obstructive pulmonary disease (COPD) using a ultrafast gas chromatography system equipped with an electronic nose detector (FGC eNose) has been developed. A prospective study was performed in 23 COPD patients and 33 healthy volunteers; exhalation breathing tests were performed with Tedlar bags. Each sample was analyzed by FCG eNose and the identification of VOCs was based on the Kovats index. Raw data were reduced by principal component analysis (PCA) and canonical discriminant analysis [canonical analysis of principal coordinates (CAP)]. The FCG eNose technology was able to identify 17 VOCs that distinguish COPD patients from healthy volunteers. At all stages of PCA and CAP the discrimination between groups was obvious. Chemical prints were correctly classified up to 82.2%25, and were matched with 78.9%25 of the VOCs detected in the exhaled breath samples. Receiver operating characteristic curve analysis indicated the sensitivity and specificity to be 96%25 and 91%25, respectively. This pilot study demonstrates that FGC eNose is a useful tool to identify VOCs as biomarkers in exhaled breath from COPD patients. Further studies should be performed to enhance the clinical relevance of this quick and ease methodology for COPD diagnosis. © 2019 John Wiley %26 Sons, Ltd.
abstract: An analytical method to identify volatile organic compounds (VOCs) in the exhaled breath from patients with a diagnosis of chronic obstructive pulmonary disease (COPD) using a ultrafast gas chromatography system equipped with an electronic nose detector (FGC eNose) has been developed. A prospective study was performed in 23 COPD patients and 33 healthy volunteers; exhalation breathing tests were performed with Tedlar bags. Each sample was analyzed by FCG eNose and the identification of VOCs was based on the Kovats index. Raw data were reduced by principal component analysis (PCA) and canonical discriminant analysis [canonical analysis of principal coordinates (CAP)]. The FCG eNose technology was able to identify 17 VOCs that distinguish COPD patients from healthy volunteers. At all stages of PCA and CAP the discrimination between groups was obvious. Chemical prints were correctly classified up to 82.2%25, and were matched with 78.9%25 of the VOCs detected in the exhaled breath samples. Receiver operating characteristic curve analysis indicated the sensitivity and specificity to be 96%25 and 91%25, respectively. This pilot study demonstrates that FGC eNose is a useful tool to identify VOCs as biomarkers in exhaled breath from COPD patients. Further studies should be performed to enhance the clinical relevance of this quick and ease methodology for COPD diagnosis. © 2019 John Wiley & Sons, Ltd.
most specific type: Document
type: Document
related by: authorship_38743
freetext keyword: COPD; electronic nose; exhaled breath; gas chromatography; multivariate analysis; volatile organic compounds 2 acetylpyridine; 2 butyloctanol; 2 methyl butanoic acid; 2 propanol; 3 hexanone; 3 methyl propanal; acetaldehyde; acrolein; alcohol derivative; aldehyde derivative; alpha pyrene; biological marker; butyraldehyde; cinnamaldehyde; cyclopentanone derivative; delta dodecalactone; hydrocarbon; indole; isobutyric acid; ketone derivative; methyl isobutyrate; octane; propionaldehyde; pyrene derivative; styrene; tetradecane; trimethylamine; unclassified drug; unindexed drug; vinylpyrazine; volatile organic compound; biological marker; volatile organic compound; adult; aged; Article; chronic obstructive lung disease; clinical article; controlled study; exhalation; female; forced expiratory volume; forced vital capacity; gas chromatography; human; lung function test; male; observational study; pilot study; predictive value; prospective study; receiver operating characteristic; sensitivity and specificity; spirometry; ultrafast gas chromatography; breath analysis; electronic nose; gas chromatography; metabolism; middle aged; procedures; reproducibility; Aged; Biomarkers; Breath Tests; Chromatography, Gas; Electronic Nose; Female; Humans; Male; Middle Aged; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Reproducibility of Results; ROC Curve; Volatile Organic Compounds
type: Thing
related by: authorship_38747
artnum: e4684
estado: published
related by: authorship_38745
related by: authorship_38742
type: Generically Dependent Continuant
issue: 12
related by: authorship_38744
related by: authorship_38749
doi: 10.1002/bmc.4684
volume: 33
type: Article
related by: authorship_38748
type: Continuant
crisid: 6029
related by: authorship_38746
type: Entity
type: Information Content Entity
pmid: 31423612
most specific type: Article
has funding vehicle: 234111
chemicalscas: 2 propanol, 67-63-0; acetaldehyde, 75-07-0; acrolein, 107-02-8; butyraldehyde, 123-72-8; cinnamaldehyde, 104-55-2; indole, 120-72-9; isobutyric acid, 5711-69-3, 79-31-2; octane, 111-65-9; propionaldehyde, 123-38-6; styrene, 100-42-5; tetradecane, 629-59-4; trimethylamine, 75-50-3; Biomarkers; Volatile Organic Compounds